|
Search
Collections
Benchmarks
Upload document
Organization
William Shomali
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
Clinical trial
Phase 2 Study of Ruxolitinib in Idiopathic Hypereosinophilic Syndrome and Primary Eosinophilic Disorders
Status: Recruiting
, Estimated PCD: 2025-11-30
